ISSN: 0939-4753
Journal Home
Journal Guideline
Nutrition, Metabolism and Cardiovascular Diseases Q1 Unclaimed
Nutrition, Metabolism and Cardiovascular Diseases is a journal indexed in SJR in Medicine (miscellaneous) and Endocrinology, Diabetes and Metabolism with an H index of 119. It has an SJR impact factor of 0,96 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 0,96.
Nutrition, Metabolism and Cardiovascular Diseases focuses its scope in these topics and keywords: adiposity, glucose, protein, ginseng, disease, intake, fruit, fructose, favourably, fatty, ...
Type: Journal
Type of Copyright:
Languages: English
Open Access Policy:
Type of publications:
Publication frecuency: -


- €
Inmediate OANPD
Embargoed OA- €
Non OAMetrics
0,96
SJR Impact factor119
H Index283
Total Docs (Last Year)987
Total Docs (3 years)12207
Total Refs3516
Total Cites (3 years)944
Citable Docs (3 years)3.43
Cites/Doc (2 years)43.13
Ref/DocOther journals with similar parameters
Nature Biomedical Engineering Q1
Journal of Thoracic Oncology Q1
Annual Review of Clinical Psychology Q1
Lancet Digital Health, The Q1
Journal of Experimental Medicine Q1
Compare this journals
Aims and Scope
Best articles by citations
Riskard 2005. New tools for prediction of cardiovascular disease risk derived from Italian population studies
View moreArginine bioavailability and endothelin-1 system in the regulation of vascular function of umbilical vein endothelial cells from intrauterine growth restricted newborns
View more16 IMPLICATION OF COMPUTER-AIMED STRATEGIES ON THE OPTIMAL MANAGEMENT OF CV RISK PROFILE IN TYPE 2 DIABETIC PATIENTS: THE "DIETA" PROJECT
View moreReceptor identification and physiological characterisation of glucagon-like peptide-2 in the rat heart
View moreEffect of dietary supplementation with glucomannan on plasma total cholesterol and low density lipoprotein cholesterol in hypercholesterolemic children
View more25 LONG-TERM EFFECTIVENESS AND SAFETY OF A NUTRACEUTICAL BASED APPROACH TO REDUCE CHOLESTEROLEMIA IN STATIN INTOLERANT SUBJECTS WITH AND WITHOUT METABOLIC SYNDROME
View moreHomeobox genes in normal and abnormal vasculogenesis
View moreIs increased uric acid a risk factor or a defensive response? The Campania Salute Network
View moreDiet, fitness and metabolic syndrome -The DR's EXTRA Study
View moreArterial function and structure after a 1-year lifestyle intervention in children with nonalcoholic fatty liver disease
View moreEndothelial dysfunction and oxidative stress in arterial hypertension
View moreThiamine deficiency leads to reduced nitric oxide production and vascular dysfunction in rats
View moreThe preventive effects of dark chocolate on impaired endothelial function in medical personnel working sequential night shifts
View more10 IMPACT OF PERIPHERAL GHRELIN ADMINISTRATION ON BODY WEIGHT, ADIPOKINE PROFILE AND LIVER FAT IN HIGH-FAT DIET OBESE RATS
View moreINS VNTR class genotype and the function of isolated human islets
View moreGlobal cardiovascular risk management in different Italian regions: An analysis of the evaluation of final feasible effect of control training and ultra sensitisation (EFFECTUS) educational program
View moreValidation of diet and urinary excretion derived estimates of sodium excretion against 24-h urine excretion in a worksite sample
View moreEffect of weight loss on inflammation in patients with mild obstructive sleep apnea
View moreWeight loss but not gains in cardiorespiratory fitness after exercise-training predicts improved health risk factors in metabolic syndrome
View moreReduced serum homocysteine levels in type 2 diabetes
View moreLifestyle determinants of c-reactive protein in middle-aged, urban Chinese men
View more8 THE METABOLIC SYNDROME DOES NOT ADD TO CAROTID ATHEROSCLEROSIS BEYOND THAT EXPECTED BY RISK FACTOR COUNTING OR RISK SCORING
View more13 INCREASED 27-HYDROXYLATION OF CHOLESTEROL IN PRIMARY HYPERCHOLESTEROLEMIA
View more17 p66shc GENE EXPRESSION IS INCREASED IN ESRD PATIENTS ON HEMODIALYSIS: RELATIONSHIPS TO SYSTEMIC OXIDATIVE STRESS, INFLAMMATION AND CLINICAL PARAMETERS
View more
Comments